{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:20:21Z","timestamp":1772090421156,"version":"3.50.1"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Perioperative management of patients on direct oral anticoagulants (DOACs) for preoperative deep vein thrombosis (DVT), pulmonary embolism (PE), or atrial fibrillation (AF), who subsequently undergo elective colorectal surgery, is a frequent clinical scenario with no clear consensus on best practices. Further complicating this issue, venous thromboembolism (VTE) and bleeding rates vary widely, ranging from 4.8% to 12.6% for VTE and 1.1% to 2.4% for bleeding, across different procedures (e.g., abdominoperineal resection, anterior resection, rectopexy, colectomy, and total proctocolectomy), as well as between countries, centers and individual surgeons. Therefore, it is necessary for surgeons to identify strategies to optimize when and how to discontinue and resume anticoagulation. Over the past decade, substantial interpatient variability in DOAC plasma levels has been observed, potentially explaining the frequent incidence of clinically relevant nonmajor bleeding (e.g., anastomotic bleeding and hematochezia) and breakthrough VTE in colorectal surgical patients. Given that pharmacokinetic factors, including genetic variations in metabolizing enzymes and efflux transporters as well as drug plasma levels measured by anti-factor Xa (FXa) activity, are associated with both the efficacy and adverse effects of anticoagulants, genotyping and anti-FXa monitoring could play a valuable role in optimizing perioperative DOAC management or enabling personalized dose adjustments. This scoping review summarizes the current evidence and proposes an integrated, personalized approach for perioperative DOAC management in colorectal surgery, with particular emphasis on procedure-specific risks, pharmacogenomics, and individualized risk prediction.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1626969","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:53:44Z","timestamp":1772088824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative management of colorectal surgical patients receiving a direct oral anticoagulant: a scoping review, particular emphasis on procedure-specific risks, and pharmacogenomics"],"prefix":"10.3389","volume":"13","author":[{"given":"Jieling","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"School of Pharmaceutical Science, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikun","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.chest.2022.11.032","article-title":"Perioperative management of vitamin K antagonists and direct oral anticoagulants: a systematic review and meta-analysis","volume":"163","author":"Shah","year":"2023","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jamasurg.2019.1165","article-title":"Assessment of anti-factor Xa levels of patients undergoing colorectal surgery given once-daily enoxaparin prophylaxis: a clinical study examining enoxaparin pharmacokinetics","volume":"154","author":"Pannucci","year":"2019","journal-title":"JAMA Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/SLA.0000000000006059","article-title":"Systematic reviews and meta-analyses of the procedure-specific risks of thrombosis and bleeding in general abdominal, colorectal, upper gastrointestinal, and hepatopancreatobiliary surgery","volume":"279","author":"Lavikainen","year":"2024","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/a-1113-0655","article-title":"Does one dose really fit all? On the monitoring of direct oral anticoagulants: a review of the literature","volume":"40","author":"Moner-Banet","year":"2020","journal-title":"Hamostaseologie"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jpm9010007","article-title":"Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants","volume":"9","author":"Kanuri","year":"2019","journal-title":"J Pers Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rcl.2018.04.006","article-title":"Imaging of the postoperative colon","volume":"56","author":"Huo","year":"2018","journal-title":"Radiol Clin North Am"},{"key":"B7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/DCR.0000000000002915","article-title":"Risk of postoperative venous thromboembolism after benign colorectal surgery: systematic review and meta-analysis","volume":"66","author":"Leow","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/DCR.0000000000001946","article-title":"Risk of postoperative venous thromboembolism after surgery for colorectal malignancy: a systematic review and meta-analysis","volume":"64","author":"Lewis-Lloyd","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11239-011-0583-8","article-title":"The incidence of deep vein thrombosis detected by routine surveillance in review ultrasound in neurosurgery patients receiving dual modality prophylaxis","volume":"32","author":"Henwood","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12957-023-03260-x","article-title":"Streamlining robotic-assisted abdominoperineal resection","volume":"21","author":"Yamada","year":"2023","journal-title":"World J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00595-021-02359-6","article-title":"Advantages of robotic abdominoperineal resection compared with laparoscopic surgery: a single-center retrospective study","volume":"52","author":"Kasai","year":"2022","journal-title":"Surg Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jss.2018.05.009","article-title":"Frequency and timing of short-term complications following abdominoperineal resection","volume":"231","author":"Tooley","year":"2018","journal-title":"J Surg Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.ejso.2024.108336","article-title":"Treatment of anterior resection syndrome: a systematic review and network meta-analysis","volume":"50","author":"Zhou","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/bjs\/znab071","article-title":"Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer","volume":"108","author":"Ryoo","year":"2021","journal-title":"Br J Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/bjs5.50128","article-title":"Low anterior resection syndrome after right- and left-sided resections for colonic cancer","volume":"3","author":"Buchli","year":"2018","journal-title":"BJS Open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/wjs.12443","article-title":"Segmental versus extended colectomy for colorectal cancer in patients with lynch syndrome: a systematic review and meta-analysis","volume":"49","author":"Pasqualotto","year":"2025","journal-title":"World J Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/MEG.0000000000002706","article-title":"Anal defecatory function in ulcerative colitis patients after total proctocolectomy and ileal pouch-anal anastomosis: a prospective cohort study","volume":"36","author":"Viazis","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/DCR.0000000000003311","article-title":"Segmental colectomy in ulcerative colitis","volume":"67","author":"Yilmaz","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"B19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/1751-2980.12658","article-title":"Postoperative bleeding after subtotal colectomy in two patients with severe ulcerative colitis","volume":"19","author":"Okada","year":"2018","journal-title":"J Dig Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/codi.16891","article-title":"National trends and outcomes of total proctocolectomy and completion proctectomy ileal pouch-anal anastomosis procedures for ulcerative colitis","volume":"26","author":"Chen","year":"2024","journal-title":"Colorectal Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/DCR.0000000000001052","article-title":"Modified pfannenstiel open approach as an alternative to laparoscopic total proctocolectomy and IPAA: comparison of short- and long-term outcomes and quality of life","volume":"61","author":"Duraes","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"B22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00384-017-2944-z","article-title":"One decade of rectal prolapse surgery: a national study","volume":"33","author":"Bjerke","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.amjsurg.2019.02.010","article-title":"Getting to the bottom of treatment of rectal prolapse in the elderly: analysis of the national surgical quality improvement program (NSQIP)","volume":"218","author":"Daniel","year":"2019","journal-title":"Am J Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.amjsurg.2020.01.017","article-title":"Rectal prolapse surgery in males and females: an ACS NSQIP-based comparative analysis of over 12,000 patients","volume":"220","author":"Vogel","year":"2020","journal-title":"Am J Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e185S","DOI":"10.1378\/chest.11-2289","article-title":"Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.thromres.2023.06.015","article-title":"Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning","volume":"228","author":"Mu\u00f1oz","year":"2023","journal-title":"Thromb Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1097\/JS9.0000000000000553","article-title":"Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study","volume":"109","author":"Wei","year":"2023","journal-title":"Int J Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1015-9584(08)60060-3","article-title":"Risk of deep vein thrombosis following laparoscopic rectosigmoid cancer resection in Chinese patients","volume":"31","author":"Cheung","year":"2008","journal-title":"Asian J Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chest.2018.09.020","article-title":"DissolVE-2 investigators. VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of Chinese hospitalized Patients\u2019 risk profile for venous thromboembolism (DissolVE-2)-A cross-sectional study","volume":"155","author":"Zhai","year":"2019","journal-title":"Chest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.accpm.2016.09.002","article-title":"Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: updated guidelines from the French working group on perioperative hemostasis (GIHP)\u2014september 2015","volume":"36","author":"Albaladejo","year":"2017","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/jth.14598","article-title":"Scientific and standardization committee communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11739-021-02866-x","article-title":"Perioperative management of antithrombotic therapy: a case-based narrative review","volume":"17","author":"Chen","year":"2022","journal-title":"Intern Emerg Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.mcna.2020.02.005","article-title":"Periprocedural management of oral anticoagulation","volume":"104","author":"Shaw","year":"2020","journal-title":"Med Clin North Am"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"EVIDra2200322","DOI":"10.1056\/EVIDra2200322","article-title":"Perioperative management of anticoagulant and antiplatelet therapy","volume":"2","author":"Douketis","year":"2023","journal-title":"NEJM Evid"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1111\/jth.15850","article-title":"Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants","volume":"20","author":"Lee","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.amjcard.2019.02.060","article-title":"Meta-Analysis of direct-acting oral anticoagulants compared with warfarin in patients >75 years of age","volume":"123","author":"Malik","year":"2019","journal-title":"Am J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1055\/s-0040-1712476","article-title":"Periprocedural direct oral anticoagulant management: the RA-ACOD prospective, multicenter real-world registry","volume":"4","author":"Ferrandis","year":"2020","journal-title":"TH Open"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ags3.12328","article-title":"Perioperative antithrombotic management of patients who receive direct oral anticoagulants during gastroenterological surgery","volume":"4","author":"Fujikawa","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2024.12708","article-title":"Perioperative management of patients taking direct oral anticoagulants: a review","volume":"332","author":"Douketis","year":"2024","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euf.2021.01.011","article-title":"Management of patients receiving direct oral anticoagulants scheduled for radical prostatectomy: an update of a prospective assessment","volume":"8","author":"Pose","year":"2022","journal-title":"Eur Urol Focus"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.2021.13844","article-title":"US emergency department visits attributed to medication harms, 2017\u20132019","volume":"326","author":"Budnitz","year":"2021","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B47","doi-asserted-by":"publisher","first-page":"101446","DOI":"10.1016\/j.accpm.2024.101446","article-title":"Prevention of perioperative venous thromboembolism: 2024 guidelines from the French working group on perioperative haemostasis (GIHP) developed in collaboration with the French society of anaesthesia and intensive care medicine (SFAR), the French society of thrombosis and haemostasis (SFTH) and the French society of vascular medicine (SFMV) and endorsed by the French society of digestive surgery (SFCD), the French society of pharmacology and therapeutics (SFPT) and INNOVTE (investigation network on venous ThromboEmbolism) network","volume":"22","author":"Godier","year":"2024","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/phar.1884","article-title":"Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know","volume":"37","author":"Conway","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jacc.2014.05.065","article-title":"Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants","volume":"64","author":"Cuker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2146\/ajhp110725","article-title":"Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient","volume":"69","author":"Miyares","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11239-015-1314-3","article-title":"Pharmacology of anticoagulants used in the treatment of venous thromboembolism","volume":"41","author":"Nutescu","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/FTD.0000000000000157","article-title":"Measurement of non-vitamin K antagonist oral anticoagulants in patient plasma using heptest-STAT coagulation method","volume":"37","author":"Du","year":"2015","journal-title":"Ther Drug Monit"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/jth.13344","article-title":"To measure or not to measure direct oral anticoagulants before surgery or invasive procedures","volume":"14","author":"Tripodi","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/bloodadvances.2020002335","article-title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","volume":"4","author":"Shaw","year":"2020","journal-title":"Blood Adv"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/eurheartj\/ehx403","article-title":"Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study","volume":"38","author":"Godier","year":"2017","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ajcp\/aqw121","article-title":"An assessment of the state of current practice in coagulation laboratories","volume":"146","author":"Zantek","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3969\/j.issn.1007-5410.2019.06.018","article-title":"Laboratory monitoring of anticoagulants","volume":"24","author":"Zhang","year":"2019","journal-title":"China Cardiovascular Journal"},{"key":"B59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"Subcommittee on control of anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B60","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annemergmed.2019.09.001","article-title":"Anticoagulant reversal strategies in the emergency department setting: recommendations of a multidisciplinary expert panel","volume":"76","author":"Baugh","year":"2020","journal-title":"Ann Emerg Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.accpm.2025.101584","article-title":"Anticoagulant management in emergency settings: 2024 guidelines from the French society of emergency medicine (SFMU), the French society of anaesthesia and intensive care medicine (SFAR), the French society of thrombosis and haemostasis (SFTH) and the French working group on perioperative haemostasis (GIHP), endorsed by the French neurovascular society","volume":"44","author":"Douillet","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrcardio.2017.223","article-title":"Reversal agents for non-vitamin K antagonist oral anticoagulants","volume":"15","author":"Levy","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.thromres.2024.04.005","article-title":"Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?","volume":"237","author":"Gendron","year":"2024","journal-title":"Thromb Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/diseases10040073","article-title":"Thromboembolic events in patients with inflammatory bowel disease: a comprehensive overview","volume":"10","author":"Gala","year":"2022","journal-title":"Diseases"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41598-021-81657-y","article-title":"Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study","volume":"11","author":"Heo","year":"2021","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cgh.2014.07.017","article-title":"Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease","volume":"13","author":"Higgins","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.suc.2019.08.007","article-title":"Abdominal emergencies in inflammatory bowel disease","volume":"99","author":"Goldstone","year":"2019","journal-title":"Surg Clin North Am"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ibd\/izaa337","article-title":"Austrian IBD study group. Inflammatory bowel disease and risk of major bleeding during anticoagulation for venous thromboembolism","volume":"27","author":"Scharrer","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00384-017-2915-4","article-title":"Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review","volume":"32","author":"Zangenberg","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"bloodadvances.2025017617","DOI":"10.1182\/bloodadvances.2025017617","article-title":"Bleeding and thrombotic outcomes in patients with inflammatory bowel disease and venous thromboembolism","author":"Dawwas","year":"2025","journal-title":"Blood Adv"},{"key":"B71","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jss.2020.05.008","article-title":"Venous thromboembolism in geriatric trauma patients-risk factors and associated outcomes","volume":"254","author":"Prabhakaran","year":"2020","journal-title":"J Surg Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jacep.2016.04.013","article-title":"Implications of frailty in elderly patients with electrophysiological conditions","volume":"2","author":"Bibas","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1503\/cmaj.101271","article-title":"Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian national population health survey","volume":"183","author":"Rockwood","year":"2011","journal-title":"CMAJ"},{"key":"B74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/agm2.12214","article-title":"Frailty and oral anticoagulant prescription in adults with atrial fibrillation: a systematic review","volume":"6","author":"Bul","year":"2022","journal-title":"Aging Med (Milton)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.4022\/jafib.1870","article-title":"What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis","volume":"10","author":"Oqab","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000535546","article-title":"Anticoagulation in patients with chronic kidney disease","volume":"55","author":"Elenjickal","year":"2024","journal-title":"Am J Nephrol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/bjh.17899","article-title":"Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients","volume":"195","author":"Kampouraki","year":"2021","journal-title":"Br J Haematol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11239-019-01815-y","article-title":"Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients","volume":"47","author":"Hirsh Raccah","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jth.15563","article-title":"Inter- and intra-individual concentrations of direct oral anticoagulants: the KIDOAC study","volume":"20","author":"Toorop","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e001208","DOI":"10.1136\/tsaco-2023-001208","article-title":"Predictors of direct oral anticoagulant concentrations in the trauma population","volume":"9","author":"Perkins","year":"2024","journal-title":"Trauma Surg Acute Care Open"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1253\/circj.CJ-18-0506","article-title":"Anti-Xa activity and event risk in patients with direct factor Xa inhibitors initiated early after stroke","volume":"82","author":"Wada","year":"2018","journal-title":"Circ J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00228-019-02693-2","article-title":"Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation","volume":"75","author":"Mikli\u010d","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2165\/11595320-000000000-00000","article-title":"Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention","volume":"50","author":"Mueck","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00210-022-02312-5","article-title":"Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors","volume":"396","author":"Ono","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jth.14001","article-title":"Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants","volume":"16","author":"Testa","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B87","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/life12050705","article-title":"Variation in plasma levels of apixaban and rivaroxaban in clinical routine treatment of venous thromboembolism","volume":"12","author":"Reda","year":"2022","journal-title":"Life (Basel)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","article-title":"Association between edoxaban dose, concentration, anti-factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Ruff","year":"2015","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"25762","DOI":"10.1038\/s41598-024-74481-7","article-title":"Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors","volume":"14","author":"Nakano","year":"2024","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00380-021-01974-0","article-title":"Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation","volume":"37","author":"Zhu","year":"2022","journal-title":"Heart Vessels"},{"key":"B91","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12603-017-0982-4","article-title":"Real-Life peak and trough dabigatran plasma measurements over time in hospitalized geriatric patients with atrial fibrillation","volume":"22","author":"Chaussade","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/jth.14457","article-title":"Coordinator of START2-register. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants","volume":"17","author":"Testa","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B93","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10557-018-6774-1","article-title":"Clinical review of the pharmacogenomics of direct oral anticoagulants","volume":"32","author":"Tseng","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"B94","volume-title":"PRADAXA (dabigatran Etexilate) [package Insert]","year":"2010"},{"key":"B95","volume-title":"SAVAYSA (edoxaban) [package Insert]","year":"2015"},{"key":"B96","volume-title":"XARELTO (rivaroxaban) [package Insert]","year":"2011"},{"key":"B97","volume-title":"ELIQUIS (apixaban) [package Insert]","year":"2012"},{"key":"B98","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/bdd.2327","article-title":"Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non-valvular atrial fibrillation","volume":"43","author":"Zhang","year":"2022","journal-title":"Biopharm Drug Dispos"},{"key":"B99","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40292-022-00536-3","article-title":"The influence of ABCB1 (rs1045642 and rs4148738) gene polymorphisms on rivaroxaban pharmacokinetics in patients aged 80 years and older with nonvalvular atrial fibrillation","volume":"29","author":"Sychev","year":"2022","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B100","doi-asserted-by":"publisher","first-page":"639854","DOI":"10.3389\/fphar.2021.639854","article-title":"Influence of ABCB1 gene polymorphism on rivaroxaban blood concentration and hemorrhagic events in patients with atrial fibrillation","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/FPC.0000000000000294","article-title":"Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation","volume":"27","author":"Ueshima","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"B102","doi-asserted-by":"publisher","first-page":"15967","DOI":"10.1038\/s41598-023-43179-7","article-title":"Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban","volume":"13","author":"Han","year":"2023","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/tpj.2016.82","article-title":"An integrated pharmacokinetic\/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure","volume":"18","author":"Vandell","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"B104","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/PGPM.S169277","article-title":"The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty","volume":"11","author":"Sychev","year":"2018","journal-title":"Pharmgenomics Pers Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/bcp.14646","article-title":"The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation","volume":"87","author":"Ji","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1182\/blood-2011-12-397752","article-title":"Multiple SNP testing improves risk prediction of first venous thrombosis","volume":"120","author":"de Haan","year":"2012","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e001060","DOI":"10.1161\/JAHA.114.001060","article-title":"Multilocus genetic risk scores for venous thromboembolism risk assessment","volume":"3","author":"Soria","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B108","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jth.12808","article-title":"Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors","volume":"13","author":"Bruzelius","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.22.00255","article-title":"A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts","volume":"41","author":"Mu\u00f1oz","year":"2023","journal-title":"J Clin Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"16492","DOI":"10.20452\/pamw.16492","article-title":"How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications","volume":"133","author":"Burggraaf","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2015.12.010","article-title":"A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)","volume":"29","author":"Franco Moreno","year":"2016","journal-title":"Eur J Intern Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e1002883","DOI":"10.1371\/journal.pmed.1002883","article-title":"Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: the Leiden thrombosis recurrence risk prediction model (L-TRRiP)","volume":"16","author":"Timp","year":"2019","journal-title":"PLoS Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41416-018-0027-8","article-title":"Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","volume":"118","author":"Mu\u00f1oz Mart\u00edn","year":"2018","journal-title":"Br J Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/pharmaceutics14091889","article-title":"Association between genetic polymorphisms and bleeding in patients on direct oral anticoagulants","volume":"14","author":"Yoon","year":"2022","journal-title":"Pharmaceutics"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2147\/DDDT.S417096","article-title":"ABCG2 gene polymorphisms may affect the bleeding risk in patients on apixaban and rivaroxaban","volume":"17","author":"Kim","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1290785","DOI":"10.3389\/fphar.2023.1290785","article-title":"Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants","volume":"14","author":"Jang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/pharmaceutics14020231","article-title":"Genetic factors of renin-angiotensin system associated with Major bleeding for patients treated with direct oral anticoagulants","volume":"14","author":"Yee","year":"2022","journal-title":"Pharmaceutics"},{"key":"B118","doi-asserted-by":"publisher","first-page":"669288","DOI":"10.3389\/fcvm.2021.669288","article-title":"Epidemiology of cancer-associated thrombosis in Asia: a systematic review","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","journal-title":"Thromb Haemost"},{"key":"B120","doi-asserted-by":"publisher","first-page":"15017644","DOI":"10.4238\/gmr.15017644","article-title":"Common genetic risk factors of venous thromboembolism in western and Asian populations","volume":"15","author":"Huang","year":"2016","journal-title":"Genet Mol Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"396","DOI":"10.12809\/hkmj219788","article-title":"Risks and impacts of thromboembolism in patients with pancreatic cancer","volume":"29","author":"Chan","year":"2023","journal-title":"Hong Kong Med J"},{"key":"B122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.thromres.2018.04.008","article-title":"Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis","volume":"166","author":"Yamashita","year":"2018","journal-title":"Thromb Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e26883","DOI":"10.1097\/MD.0000000000026883","article-title":"Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: a PRISMA-compliant article","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2021.02.024","article-title":"Venous thromboembolism in Asia and worldwide: emerging insights from GARFIELD-VTE","volume":"201","author":"Angchaisuksiri","year":"2021","journal-title":"Thromb Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1626969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:53:46Z","timestamp":1772088826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1626969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":124,"alternative-id":["10.3389\/fcvm.2026.1626969"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1626969","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1626969"}}